(Health-NewsWire.Net, January 21, 2017 ) DelveInsight Report, "Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.
For More Information About This Report: http://www.reportsweb.com/chimeric-antigen-receptor-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2016
Report Scope:
- CAR-T cell Therapy Pipeline scenario - Collaborations & partnering deals - Current Prominent Research Areas and Key Players - Pipeline product profiles CAR-T Technologies and Targeted Antigens - Licensing opportunities - Market Drivers and Barriers Request Sample Copy At: http://www.reportsweb.com/inquiry&RW0001109526/sample
Reasons to Buy:
- Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities - Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas - Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies - Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development - Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years - Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising
Inquire for Report At: http://www.reportsweb.com/inquiry&RW0001109526/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|